Text

Advances in Infectious Diseases and Clinical Microbiology during the COVID-19 Pandemic

---

Background and Objectives: Aspirin (ASA) is a commonly used antithrombotic drug that
has been demonstrated to reduce venous thromboembolism. The aim was to analyze if geriatric
COVID-19 patients undergoing a 100 mg/day Aspirin (ASA) treatment prior to hospitalization differ
in hospital outcome compared to patients without previous ASA therapy. Materials and Methods:
An observational retrospective study was carried out using an anonymized database including
geriatric COVID-19 patients (March to April 2020) admitted to Madrid Hospitals Group

---

Availability

No copy data

Detail Information

Series Title

-

Call Number

-

Publisher

: MDPI - Multidisciplinary Digital Publishing Institute., 2023

Collation

250

Language

English

ISBN/ISSN

9783036594682

Classification

NONE

Content Type

text

Media Type

computer

Carrier Type

online resource

Edition

-

Subject(s)

Infectious Diseases
Clinical Microbiology during the COVID-19 Pandemic

Specific Detail Info

-

Statement of Responsibility

-

Other Information

Cataloger

Angga

Source

-

Validator

-

Digital Object Identifier (DOI)

https://mdpi-res.com/bookfiles/book/8325/Advances_in_Infectious_Diseases_and_Clinical_Microbiology_during_the_COVID19_Pandemic.pdf?v=1763431753

Journal Volume

-

Journal Issue

-

Subtitle

-

Parallel Title

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment